Vorapaxar antiplatelets drug
systematic review meta-analysis network meta-analysis
 

SCH-530348 - SCH530348 - SCH 530348 - •Zontivity      

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathcardiovascular events

acute coronary syndrome  

TRACER, 2011      NCTvorapaxarplacebo (on top standard therapy) Low risk of bias -

cardiovascular prevention  

TRA-2P TIMI 50, 2012        NCTvorapaxarplacebo (on top aspirin)secondary preventionLow risk of bias suggesting -4%-13%
TRA-2P TIMI 50 (no prior stroke sub group), 2012     vorapaxarplacebo (on top aspirin)secondary preventionExploratory suggesting-16%
TRA-2P TIMI 50 (MI subgroup), 2012        NCTvorapaxarplacebo (on top aspirin)secondary preventionExploratory suggesting -7%-19%

post myocardial infarction  

TRA-2P TIMI 50, 2012        NCTvorapaxarplacebo (on top aspirin)secondary preventionLow risk of bias suggesting -4%-13%



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons